MKSI
MKS Instruments
Summary
What they do:
Manufacture the instruments, subsystems, and process control technologies embedded inside every major semiconductor equipment tool — vacuum gauges, RF power supplies, mass flow controllers, pressure sensors, and industrial lasers that enable precise deposition, etch, and measurement in chip fabrication.
Why they matter:
MKS is the measurement and control backbone of the semiconductor equipment ecosystem. Their components are inside virtually every AMAT, LRCX, and TEL tool. When a deposition chamber needs precise vacuum control, RF power delivery, or gas flow measurement, MKS instruments make that possible. Revenue was $3.9B in 2025, making it the largest subsystem/instrument company in the WFE supply chain.
Recent performance:
FY2025 revenue $3.9B, up 10% YoY; EPS grew 20%; free cash flow grew 21% to $497M. Q4 revenue $1.03B, up 5% sequentially and 10% YoY. Semiconductor revenue $435M (+9% YoY), led by plasma/reactive gases and DRAM/logic-foundry strength. Electronics & Packaging $303M (+19% YoY); chemistry sales +16% YoY ex-FX/palladium. AI-related chemistry doubled from 5% to 10% of E&P chemistry, growing sequentially every quarter in 2025. Net debt reduced to $3.6B (3.7x net leverage). Q1 2026 guided $1.04B +/- $40M. Stock ~$270, market cap ~$18B. Reports Q1 2026 on April 28.
Our Verdict
The broadest process control and instrument franchise in semiconductor equipment with $3.9B revenue and exposure to every major WFE tool, plus a growing AI-driven electronics/packaging chemistry business — but at ~4.6x trailing revenue and ~20x forward P/E, fairly valued for a cyclical compounder.
Structural trends
Structural
78
/ 100
Moat
6/10
Broadest instrument portfolio + OEM qualification depth + Atotech chemistry, competitive per category
AI Exp.AI Exposure
Embedded~20% AI
Play Type
EstablishedAI Growth
~15%
Rel. Value
78
COMPELLINGInside every semiconductor equipment tool — whether it's an AMAT deposition system, an LRCX etch chamber, or a TEL thermal processing unit — there's a constellation of instruments and subsystems that make the tool work. Vacuum gauges measure chamber pressure to 10^-9 torr. RF power supplies deliver precise energy to plasma chambers. Mass flow controllers regulate process gas delivery to parts-per-billion accuracy. Pressure sensors, optical components, and motion systems complete the measurement and control infrastructure. MKS Instruments makes all of these.
The company operates across three segments. Vacuum & Analysis (~35% of revenue) includes vacuum products, analytical instruments, and control solutions for semiconductor and industrial applications. Photonics (~30%) manufactures lasers, optics, and photonics subsystems used in semiconductor equipment, electronics manufacturing, and industrial processing. Materials & Solutions (~35%) provides specialty chemicals, advanced materials, and deposition materials — including the Atotech electronic packaging chemistry business acquired in 2022.
The Atotech acquisition is strategically significant. It brought in specialty chemistry for PCB manufacturing, including materials used in AI-driven high-layer-count PCBs. CEO John Lee quantified the layer-count story on Q4's call: smartphone PCBs run 10-12 layers, but AI HDI boards are already at 15-20 layers, AI multilayer boards (MLB) are 30-40 layers, and AI package substrates add further layers -- with HDI and MLB growing by 10+ layers per year. AI-related chemistry grew from 5% of E&P chemistry in 2024 to 10% in 2025, rising sequentially every quarter. Chemistry equipment bookings remained strong for a fifth consecutive quarter; management said every $100M of equipment shipped translates to $20-40M in annual chemistry revenue at full utilization, with an 18-24 month lag from equipment install to chemistry revenue ramp. The equipment shipped in 2021-2022 is what drove 2025 chemistry growth; equipment shipping now seeds 2026-2027 chemistry revenue streams.
FY2025 revenue was $3.9B: semiconductor $1.7B (+13% YoY, outperforming WFE), Electronics & Packaging $1.1B (+20% YoY), Specialty Industrial $1.1B (-4% YoY on auto/industrial softness). Full-year chemistry sales grew 11% ex-FX/palladium. Gross margin was 46.7% (down 90 bps YoY due to tariffs and chemistry-equipment mix), with tariff impact largely mitigated dollar-for-dollar by Q4 but still weighing ~50 bps on margin. Full-year operating margin 20.7%; adjusted EBITDA $966M (24.1% margin in Q4). Operating cash flow $645M; free cash flow $497M (+21% YoY).
MKS is expanding capacity with a new supercenter factory in Malaysia ramping mid-2026, designed as a long-term business-continuity and future-capacity play (not built for this specific ramp). CEO Lee said existing factories are already ready for $125B WFE with 30% surge capacity. The company also has a Thailand facility ramping for chemistry. MKS supports ~85% of WFE tools, positioning it to capture virtually all of the multi-year upcycle.
Supply Chain Dependencies
The Catch
MKS carries $3.6B net debt (3.7x net leverage on $966M 2025 EBITDA) from the Atotech acquisition. While down from $5B+ at close and improving via $500M+/year FCF, net interest expense is still $42M/quarter ($168M/year), and the leverage constrains the stock's multiple and amplifies downside risk if the WFE cycle turns. In a semiconductor downturn, MKS's earnings would compress faster than debt-free competitors like KLA or ASML. The Feb 2026 refinancing helps ($27M/year interest savings, maturities extended, revolver expanded to $1B), but the structural risk remains. The AI chemistry angle is real and growing, but at 10% of E&P chemistry (which is itself ~28% of total revenue), it represents a small portion of a $3.9B business. If you're buying MKS for AI exposure, you're also buying a leveraged bet on the broader WFE cycle.
If They Win
If the WFE super cycle runs through 2028 (CEO Lee: customers and peers pointing to 15-20% WFE growth in 2026, and "more than just a 1-year thing"), MKS rides its ~85% WFE coverage and historical outperformance in upturns. Semiconductor revenue hits the "$500M handle" by H2 2026, pushing toward $2B+ annual semi run rate. Meanwhile, 2 years of record chemistry equipment shipments (2025-2026) seed $200M+ in annual recurring AI chemistry revenue by 2027-2028, at gross margins above the corporate average (chemistry is high-margin; equipment is lower). The Malaysia and Thailand capacity expansions come online mid-cycle, enabling share gains without constraining customers. Net leverage drops below 2.5x as $500M+/year FCF compounds against declining debt, and the $27M/year interest savings from the Feb 2026 refinancing accelerates the glide. At that point, MKS is a $5B+ revenue company with sub-2.5x leverage, a growing chemistry annuity, and the broadest instrument portfolio in WFE. The stock re-rates from 20x to 25x forward earnings — $380–400. The NAND upgrade cycle adds upside optionality beyond that.
Others in Build the Machines That Make the Chip
Not financial advice. All scores generated via AI algorithms using public data.